Search

everythinglearnresearchcommunity

for

Search:↓

Self-assessed hirsutism scores are not reliable for clinical diagnosis but may help in screening.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

Patients with traumatic brain injury need comprehensive care to improve their well-being.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Children with alopecia areata and their caregivers experience significant emotional and quality of life challenges.

Psoriasis patients are more likely to experience maladaptive daydreaming.

A hair test shows promise for early mood disorder diagnosis.

Finasteride is not proven to cause depression or suicide, and careful patient monitoring is advised.

Poor body image from pain can lead to more depression in lupus patients.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Hair cortisol could be a marker for chronic stress in pregnancy, but depression affects cortisol levels differently.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Maidenhair fern extract reduced anxiety and depression in rats and may work due to its antioxidant and anti-inflammatory properties.

The FAW-FS algorithm improves depression recognition, and psychological interventions help AGA patients' mental health.

Medications for benign prostatic syndrome can cause cognitive issues and depression.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Long-term Finasteride treatment reduces depression better than short-term treatment in rats.

Alopecia areata greatly affects quality of life, needing psychological support.

Women with alopecia often experience high levels of anxiety and depression, needing psychiatric help.

People with polycystic ovary syndrome often experience anxiety and depression.

Finasteride can cause depression and suicidal thoughts; safer alternatives are recommended.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

Mental health issues affect adaptation in alopecia patients more than the cause of hair loss.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Higher self-esteem in men with androgenic alopecia leads to less shame and more openness.